Global Hair Transplant Market: Future Demand, Analysis & Outlook to 2027

Global Hair Transplant Market: Future Demand, Analysis & Outlook to 2027

The global hair transplant market share is anticipated to accrue considerable gains over the forecast spell, owing to a rapid surge in the number of people suffering from hair loss worldwide. Studies suggest that over 50 million men and 30 million women across the U.S. suffer from hair loss and hair thinning.

Given these statistics, hair restoration therapies such as PRP (platelet-rich plasma) are gaining widespread preference in recent years, and in turn, augmenting industry outlook.

Request for a sample copy of this report @

The hair transplant market is categorized into various segments based on product, method, and therapy type. Robust growth in the industry is attributed mainly to rapid technological advancements, affordability, and automation in hair loss treatments. Factors such as burgeoning demand for single-session hair transplant surgeries and intensifying focus on personal physical appearance are major contributors to global hair transplant industry expansion.

According to Global Market Insights, Inc. estimates, the hair transplant market size is anticipated to surpass $40.1 billion by 2026.

With respect to gender, the hair transplant industry is segmented into female and male segments. Of these, the male segment is set to exhibit a CAGR of over 25.8% through 2026, as a result of a prolific rise in male population suffering from severe hair fall disorders due to genetic factors as well as unhealthy lifestyles and inadequate diets.

Request for customization @

According to studies, nearly 25% of men with genetic hair loss conditions start to lose their hair before 21 years of age. This rising prevalence of hair loss among younger populations, coupled with rising awareness of myriad hair restoration therapies and higher disposable incomes are likely to contribute to a favorable hair transplant market forecast over the projected timeframe.

Proliferating cases of hair loss among populations in the Middle East and Africa region are also adding impetus to industry expansion in recent years. Some reports claim that almost 60% of the male population in the Middle East are susceptible to hair loss in their lifetime, in comparison with the global average of 40%. One of the common causes of male pattern baldness is the growing sensitivity of hair follicles to hormones such as DHT (dihydrotestosterone) on the scalp, which binds with and shrinks follicles until they can no longer generate visible hair.

To address this issue, companies such as Italian biotech firm Cassiopea are developing unique and advanced hair loss treatments. For instance, the company’s Breezula treatment is designed to create a direct barrier to adverse DHT impact on the scalp, by leveraging an action mechanism developed via analyzing the role of the hormone in acne development. The treatment, which has already completed successful phase II trials, and has a phase III trial in the works, is set to become the first novel treatment for male pattern baldness in the years ahead.

In terms of segmentation by method, the hair transplant industry is bifurcated into FUE (follicular unit extraction) and FUT (follicular unit transplantation). Among these, the FUE (Follicular Unit Extraction) segment accounted for a major revenue share in 2019, registering remuneration worth over $3,270 million. This robust market size was a result of the growing prevalence of male pattern baldness among global populations, and the subsequent surge in adoption of myriad hair restoration therapies by practitioners and surgeons. Moreover, the rising number of alopecia cases, alongside a proliferating elderly population base worldwide is poised to enhance the global hair transplant market outlook from the segment over the coming years.

Meanwhile, the hair transplant market from the drugs segment is set to register a CAGR of over 25.5% through 2026. This growth is attributed mainly to the growing demand for hair loss treatment drugs that demonstrate high potential in the treatment of conditions like alopecia with minimal side effects. Furthermore, strong investment efforts by industry leaders towards developing innovative hair transplant drugs will boost industry growth from the segment.

From a therapy perspective, the hair transplant business landscape is bifurcated into stem cell therapy, platelet-rich plasma (PRP), laser therapy, and others. Of these, the PRP (platelet-rich plasma) therapy held a commendable revenue share, registering a valuation of over $358 million in 2019. PRP is rapidly emerging as one of the most advanced and innovative hair restoration therapies in recent years, designed to provide relief to patients suffering from hair thinning or loss.

With over 20 growth factors considered essential for hair regrowth, via stimulation of new hair cells, the PRP hair transplant procedure is likely to gain massive traction worldwide, which could accelerate hair transplant market development over the estimated timeline.

Partial Chapter of the Table of Content

Chapter 3.  Hair Transplant Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry impact forces

3.3.1.  Growth drivers  Increase in number of people suffering from hair loss in Middle East and Africa  Rising awareness regarding physical appearance and hair loss in developing regions of Asia Pacific  Technological advancements in North America and Europe  Changing lifestyle of people across the globe

3.3.2.  Industry pitfalls & challenges  Adverse drug side effects  Cost of treatment  Lack of reimbursement policies and insurance coverage

3.4. Growth potential analysis

3.4.1.  By method

3.4.2.  By product

3.4.3.  By therapy

3.4.4.  By gender

3.4.5.  By service provider

3.5. COVID-19 impact analysis

3.6. Porter’s analysis

3.7. Competitive landscape, 2019

3.7.1.   Strategy dashboard

3.8.   PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @